Clinical Trial Update: Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports results comparing cariprazine to placebo in Bipolar I Depression, assessing efficacy, safety, and tolerability with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Vraylar (cariprazine) (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar Disorder, Depression | Phase 3 | Status: COMPLETED | Results posted: 2019-01-30